Bereznicki LR[au] - Search Results

Year	Number of Results
2004	2
2005	3
2006	4
2007	1
2009	1
2010	2
2011	5
2012	4
2013	6
2014	6
2015	5
2016	14
2017	13
2018	10
2019	5
2020	8
2021	9
2022	9
2023	2

1

Actual drug-related harms in residential aged care facilities: a narrative review.

Ali S, Curtain CM, Bereznicki LR, Salahudeen MS. Ali S, et al. Among authors: bereznicki lr. Expert Opin Drug Saf. 2022 Aug;21(8):1047-1060. doi: 10.1080/14740338.2022.2084071. Epub 2022 Jun 2. Expert Opin Drug Saf. 2022. PMID: 35634890 Review.

2

New antithrombotics for atrial fibrillation.

Bereznicki LR, Peterson GM. Bereznicki LR, et al. Cardiovasc Ther. 2010 Oct;28(5):278-86. doi: 10.1111/j.1755-5922.2010.00209.x. Epub 2010 Jul 14. Cardiovasc Ther. 2010. PMID: 20645985 Free article. Review.

3

Switching of oral anticoagulants in patients with nonvalvular atrial fibrillation: A narrative review.

Kefale AT, Peterson GM, Bezabhe WM, Bereznicki LR. Kefale AT, et al. Among authors: bereznicki lr. Br J Clin Pharmacol. 2022 Feb;88(2):514-534. doi: 10.1111/bcp.15021. Epub 2021 Oct 13. Br J Clin Pharmacol. 2022. PMID: 34350609 Free article. Review.

4

The risks of warfarin use in the elderly.

Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC. Bereznicki LR, et al. Expert Opin Drug Saf. 2006 May;5(3):417-31. doi: 10.1517/14740338.5.3.417. Expert Opin Drug Saf. 2006. PMID: 16610970 Review.

5

Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia.

Zaidi AS, Peterson GM, Bereznicki LRE, Curtain CM, Salahudeen MS. Zaidi AS, et al. Among authors: bereznicki lre. Ther Adv Drug Saf. 2022 Mar 11;13:20420986221080796. doi: 10.1177/20420986221080796. eCollection 2022. Ther Adv Drug Saf. 2022. PMID: 35295667 Free PMC article.

6

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation.

Obamiro KO, Chalmers L, Bereznicki LR. Obamiro KO, et al. Among authors: bereznicki lr. Am J Cardiovasc Drugs. 2016 Oct;16(5):349-63. doi: 10.1007/s40256-016-0171-6. Am J Cardiovasc Drugs. 2016. PMID: 27262433 Review.

7

Persistent pain management in Australian general practice.

Veal FC, Thompson AJ, Bereznicki LR, Peterson GM. Veal FC, et al. Among authors: bereznicki lr. Aust J Prim Health. 2017 Apr;23(2):105-106. doi: 10.1071/PY16141. Aust J Prim Health. 2017. PMID: 28442053 No abstract available.

8

Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.

Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Angamo MT, et al. Among authors: bereznicki lr. Drug Saf. 2016 Sep;39(9):847-57. doi: 10.1007/s40264-016-0444-7. Drug Saf. 2016. PMID: 27449638 Review.

9

Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants.

Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, Bindoff I, Peterson GM. Bezabhe WM, et al. Among authors: bereznicki lr. Expert Rev Clin Pharmacol. 2022 Mar;15(3):359-364. doi: 10.1080/17512433.2022.2070151. Epub 2022 May 1. Expert Rev Clin Pharmacol. 2022. PMID: 35452586

10

Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool.

Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR. Parameswaran Nair N, et al. Among authors: bereznicki lr. Clin Interv Aging. 2016 May 2;11:497-505. doi: 10.2147/CIA.S99097. eCollection 2016. Clin Interv Aging. 2016. PMID: 27194906 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results